Kroll commissioned the Economist Intelligence Unit to conduct a worldwide survey on fraud and its effect on business in 2009/2010.
Kroll's Global Fraud Report brings together these survey results with the experience and expertise of Kroll and a selection of its affiliates. more
Browse Archives Healthcare & Pharma
Mexico’s Shadow Pharma MarketNovember 2009 | Guillaume Corpart, Manuel D’Andrea & Enrique Orellana, Mexico City
Pharmaceutical Packaging: Key marketing tool for a booming industryApril 2008| Mario Rubio
Fraud and Counterfeiting in the Pharmaceutical Industry: Preventative Advice from KrolMarch 2008 | Vander Giordano
|
An in-depth investigation reveals a host of problems afflicting Mexico’s pharmaceutical industry. Counterfeiting, theft and illegal sales of samples cost drug-makers nearly US$2 billion a year.
In an increasingly competitive pharmaceutical market, manufacturers must strive to remain competitive and appeal to the ever more-informed consumer. The sales of any consumer product are determined by a series of factors; packaging being one of the most important. The case is no different for pharmaceuticals, where primary and secondary packaging play a decisive role in the sales of any given medication.
Latin America remains a promising region for the international pharmaceutical industry, with major companies like Pfizer and Johnson & Johnson well represented in the region for over 50 years. Pharmaceutical companies have weathered the region’s economic crises but frequently point to the issue of intellectual property protection as a hindrance to further investment. Pharmaceutical fraud – mainly counterfeiting – has had a deep economic impact on the industry. According to the Federal Drug Association, 40% of all drugs sold in Argentina, Colombia and Mexico were counterfeit.